About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01256593

Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)

The objective of this Investigation is to evaluate the safety and efficacy of Lyrica in medical practice. Also, occurrence of unknown and known adverse drug reactions (ADRs) in subjects treated with L...

Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

All the patients whom an investigator prescribes the first Lyrica® should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Age

0 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients need to be administered Lyrica® in order to be enrolled in the surveillance.

Exclusion Criteria

•Patients not administered Lyrica®.

Related studies

The Will Erwin Headache Research Center - Cluster Headache Study

NCT02910323 · Cluster Headache, Cluster Headaches and Other Trigeminal Autonomic Cephalgias, and more

Virtual Reality (VR) Self-Hypnosis Software

NCT06398847 · Musculoskeletal Pain, Neuropathic Pain, and more

Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.

NCT06290661 · Postherpetic Neuralgia, Peripheral Neuropathic Pain, and more

Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain

NCT04144972 · Spinal Cord Injuries, Nerve Injury, and more

Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet Rich Plasma to Treat Idiopathic Glossopharyngeal Neuralgia (GPN)

NCT06931457 · Glossopharyngeal Neuralgia, Pulsed Radiofrequency, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 15, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment3,827

Start dateFeb 2011

Last updatedSep 15, 2023

Condition

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 15, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions